SCHEMBL13838583

SCHEMBL13838583

COc1ccc(/C(=N/O)c2ccc(N)nc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.47
ALDH1A1 P00352 2/20 0.47
GABRP O00591 1/20 0.42
GABRD O14764 1/20 0.42
GABRA1 P14867 1/20 0.42
GABRB1 P18505 1/20 0.42
GABRG2 P18507 1/20 0.42
GABRB3 P28472 1/20 0.42
GABRA5 P31644 1/20 0.42
GABRA3 P34903 1/20 0.42
GABRA2 P47869 1/20 0.42
GABRB2 P47870 1/20 0.42
GABRA4 P48169 1/20 0.42
GABRE P78334 1/20 0.42
GABRA6 Q16445 1/20 0.42
GABRG1 Q8N1C3 1/20 0.42
GABRG3 Q99928 1/20 0.42
GABRQ Q9UN88 1/20 0.42
NNMT P40261 1/20 0.42
KDM4E B2RXH2 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13727146 0.86 SMN1; SMN2 (0.42) SMN1; SMN2ALDH1A1GABRPGABRDGABRA1
SCHEMBL13727145 0.86 SMN1; SMN2 (0.42) SMN1; SMN2ALDH1A1GABRPGABRDGABRA1
SCHEMBL244032 0.81 SMN1; SMN2 (0.68) SMN1; SMN2ALDH1A1KDM4EMAPTHPGD
SCHEMBL13838568 0.76 SMN1; SMN2 (0.47) SMN1; SMN2ALDH1A1GABRPGABRDGABRA1
SCHEMBL875642 0.74 MGLL (0.60) SMN1; SMN2ALDH1A1KDM4EMAPTHPGD
SCHEMBL333949 0.73
SCHEMBL29715865 0.73
SCHEMBL18228137 0.73 NNMT (0.58) SMN1; SMN2ALDH1A1NNMTKDM4EMAPT
SCHEMBL4500005 0.71 LTA4H (0.61) MAPTKMT2AMAP4K4CHEK2
SCHEMBL4927587 0.69 NNMT (0.49) SMN1; SMN2ALDH1A1GABRA5NNMTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012151355-A1 COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2012-11-08 WO disclosed